Рет қаралды 588
The obesity and diabetes epidemic shows no sign of slowing down and there are projections that by 2030, 60 million people might not be able to access affordable insulin. Stephen Saad, CEO of Aspen Pharmacare has more on this. Courtesy of #DStv403